10-87952261-T-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000314.8(PTEN):c.634+2T>G variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000314.8 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.634+2T>G | splice_donor_variant, intron_variant | Intron 6 of 8 | ENST00000371953.8 | NP_000305.3 | ||
PTEN | NM_001304717.5 | c.1153+2T>G | splice_donor_variant, intron_variant | Intron 7 of 9 | NP_001291646.4 | |||
PTEN | NM_001304718.2 | c.43+2T>G | splice_donor_variant, intron_variant | Intron 6 of 8 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome Pathogenic:1
This sequence change affects a donor splice site in intron 6 of the PTEN gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PTEN are known to be pathogenic (PMID: 9467011, 21194675). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of PTEN hamartoma tumor syndrome (PHTS) (PMID: 15372512, 23335809, 30528446). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 167550). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.634+2T>G intronic pathogenic mutation results from a T to G substitution two nucleotides after coding exon 6 of the PTEN gene. This mutation was identified in a single individual meeting clinical diagnosis of Cowden syndrome from a cohort of 154 European individuals with deleterious germline PTEN mutations. In particular, this individual was affected with mucocutaneous lesions, oral mucosal papillomatosis, macrocephaly and gastrointestinal polyps (Bubien V et al. J Med Genet. 2013 Apr;50(4):255-63). In addition to the clinical data presented in the literature, since alterations that disrupt the canonical splice donor site are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at